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ABSTRACT 
Introduction 
Bariatric surgery is an important treatment for the worldwide increasing epidemic of obesity. 
However, the effects of such surgery on offspring epigenetic profile and effects on objectively 
measured physical activity and sedentary behavior in women undergoing bariatric surgery and 
family members are essentially unknown.  
Aim 
The aim of this thesis was to investigate possible effects of maternal weight loss after bariatric 
surgery and effects on differences in maternal gestational weight gain in repeated pregnancies 
of the same women on sibling body size in childhood, epigenetic profile and physical activity 
among siblings and spouses. 
Methods 
Longitudinal studies with repeated objective measures in the same women, spouses and 
offspring before and after maternal bariatric surgery.   
Results 
There were positive associations, in women undergoing bariatric surgery (n = 124), between 
differences in total and second trimester gestational weight gain and differences in offspring 
birth weight. 
Maternal bariatric surgery, with subsequent weight loss between pregnancies, is associated with 
overrepresentation of differences in methylated sites in genes involved in inflammation and 
type-2 diabetes signaling when comparing offspring born before (n = 31) and after (n = 31) 
maternal bariatric surgery. 
There were no significant differences in objectively measured physical activity or time spent 
sedentary from three months before to nine months after surgery in women undergoing Roux-
en-Y Gastric Bypass (n = 56), despite substantial weight loss. 
Objectively measured physical activity and time spent sedentary three months before and nine 
months after the women’s Roux-en-Y Gastric Bypass did not differ significantly in spouses (n 
= 33). However, during the same period, physical activity decreased significantly in children (n 
= 75), while time spent sedentary increased significantly. 
Conclusion 
Interpregnancy differences in gestational weight gain, in women undergoing bariatric surgery, 
are associated with increased differences in offspring birth weights and differences in the 
epigenetic regulation of obesity-related genes in comparison of siblings born before and after 
maternal bariatric surgery. Furthermore, large weight loss after maternal Roux-en-Y Gastric 
Bypass is not associated with significant change in physical activity or time spent sedentary in 
women or spouses, while children decrease physical activity and increase time spent sedentary 
from three months before to nine months after maternal Roux-en-Y Gastric Bypass.   
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1 INTRODUCTION 
1.1 DEFINITIONS 
Overweight and obesity 
In order to internationally measure and monitor overweight and obesity in a standardized 
manner the Department of Nutrition and Health and Development, together with the World 
Health Organization (WHO), developed the WHO Global Database on body mass index (BMI) 
(1). BMI is non-invasive, easy to use and at present frequently used to measure overweight and 
degree of obesity. However, BMI has its limitations: it does not measure body fat or muscle 
distribution, and does not take into account the changes in body composition that occur with 
age (2).   
BMI is calculated by dividing the individual’s weight in kilograms by the square of their height 
in meters. The WHO definition of BMI, often used to calculate excess body weight and excess 
body weight loss, is presented in Table 1 (1). 
Table 1. Classification of BMI according to the World Health Organization (WHO) 
Classification of BMI according to WHO 
BMI Classification 
18.5 – 24.9 Normal weight 
25 – 29.9 Overweight 
30 – 34.9 Class I obesity 
35 – 39.9 Class II obesity 
≥ 40 Class III obesity 
Since BMI in childhood changes substantially with age (3), cut-off points related to age are 
necessary to define child obesity. Therefore, an international standard definition, connected to 
adult cut-off points, is used when defining child overweight and obesity (4).  
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Gestational weight gain 
Gestational weight gain (GWG) is a product of the growing fetus and placenta, increasing 
volume of maternal blood and water, and gain in adipose tissue (5). Table 2 demonstrates the 
2009 Institute of Medicine (IOM) published and revised GWG guidelines, which are based on 
pre-pregnancy BMI ranges for underweight, normal-weight, overweight, and obese women (6).  
Table 2. Institute of Medicine guidelines for GWG depending on pre-pregnancy BMI 
 Pre-pregnancy BMI (kg/m2) Total GWG (kg) 
Underweight <18.5 12.7 – 18.2 
Normal weight 18.5 – 24.9 11.4 – 15.9 
Overweight 25.0 – 29.9 6.8 – 11.4 
Obese ≥ 30.0 5.0 – 9.1 
Physical activity   
Physical activity (PA) is defined as bodily movement produced by skeletal muscles that results 
in energy expenditure (7). Energy expenditure has three components: basal metabolic rate, the 
thermic effect of food, and energy expenditure due to PA which is a major modifiable variable 
for an individual’s regulation of energy expenditure. PA is a behavior that can be further 
divided into different categories: leisure-time activity, occupational activity, automatic 
movements, and exercise, which is a type of leisure-time activity that is planned, structured and 
repetitive and done to improve or maintain physical fitness (8).  
Intensity, frequency and duration are the three components that determine the effect of PA. The 
intensity of PA is often described in terms of MET (metabolic equivalent), which is the ratio of 
work metabolic rate during an activity to resting metabolic rate. MET describes the energy cost 
of physical activities, and therefore the rate of energy consumption during a specific physical 
activity to a reference metabolic rate. One MET is set as the resting metabolic rate obtained 
during quiet sitting. Light PA (LPA) is considered to range from 1.5 to 3.0 METs, and 
Moderate-to-Vigorous PA (MVPA) to be at 3.0 METs or more (9).   
Sedentary behavior 
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Sedentary behavior (SB) is defined as waking behavior resulting in energy expenditure lower 
than 1.5 METs while in a sitting or reclining position (10). SB implies muscular inactivity within 
the large muscle groups of the body, and is thereby characterized by low energy expenditure. 
Epigenetics 
The term epigenetics was originally described in the early half of the 20th century in terms of 
causal interactions by genes and their products affecting the phenotype (11). Nowadays, 
epigenetics is generally accepted as ‘‘the study of changes in gene function that are mitotically 
and/or meiotically heritable and that do not entail a change in DNA sequence’’ (12). Epigenetic 
modifications include DNA methylation of cytosine residues at the carbon five positions, 
histone modifications (e.g., acetylation, ubiquitylation), and also the effects of non-coding 
RNAs (13). DNA methylation was the first epigenetic modification described at a molecular 
level (14) and has since then been the most widely studied to date, especially in the context of 
molecular epidemiology (15).   
 
1.2 BACKGROUND 
The co-morbidities of overweight and obesity, such as cardiovascular disease, several cancer 
forms and type-2 diabetes (T2D), kill at least 2.8 million adults worldwide each year (16).  
During the last few decades, the prevalence of overweight and obesity in Sweden has increased, 
with approximately 50% of men, 40% of women and 10% of children now overweight, and 
14% of both men and women and 5% of children obese (17) (18), which reflects a more than 50% 
increase from 1980 to 2012 in men and women (19). Moreover, the prevalence of overweight 
and obesity among women in early pregnancy has increased rapidly in Sweden, from 10.6% 
and 2.1%, respectively, in 1982 to 24.8% and 12.6% in 2010 (20). This is of special concern as 
obesity during pregnancy is a major risk factor for complications in pregnancy and delivery, 
including gestational diabetes, and increased offspring birth weight, which in turn are risk 
factors for childhood obesity (21). In addition, large maternal GWG is associated with increased 
birth weight and risk of obesity in offspring (22). However, the etiology of childhood obesity, 
which is an established major public health problem (23), is complex and influenced by 
inheritance of the parents’ obesity-related genes, their eating and PA behaviors, and possibly 
also by structural conditions such as family factors and the community physical activity 
environment (24).  
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Causes of obesity 
An increase in size and most likely also the number of fat cells in adults are vital to the 
development of obesity (25). The simple explanation for this phenomenon is an anomaly in 
energy balance (26). However, it is not known whether it is a decrease in PA or an increase in 
energy intake, over the past decades, which explains the majority of the increases seen in the 
prevalence of obesity in large parts of the world. There seems to be evidence for both reduced 
expenditure of intake and increased energy intake (27-29). The imbalance itself can be further 
subdivided into the genetic, epigenetic and environmental factors, and is most likely a 
combination of them all (30). The gene-environment factor is generally seen as one of the major 
contributors to increases in obesity (30), and the link between genes and environment may be 
explained by epigenetic variations due to environmental influences on gene expression (31). 
Furthermore, twin-data from Silventoinen et al. indicate that PA modifies the degree of genetic 
influence on obesity where individuals who are at greatest genetic risk of developing obesity 
would benefit the most from increasing their PA (32).    
Co-morbidities of obesity 
Only a few of the numerous co-morbidities that accompany obesity, with different strengths of 
association, are included in this thesis. T2D is a common co-morbidity strongly associated with 
obesity (33), which seems to increase with severity of obesity (34). High blood pressure is another 
common co-morbidity associated with obesity that likewise increases with severity of obesity 
(34). Furthermore, cardiovascular disease (35) and increased cardiovascular-related mortality are 
strongly associated with obesity (36). Several cancer forms, such as pancreatic, colorectal, and 
postmenopausal breast and kidney cancer, are associated with obesity (16). With all these co-
morbidities and their associations with obesity, it is not surprising that mortality is elevated by 
increasing obesity (37). The increased risk of BMI-related mortality seems to be higher among 
younger individuals, although the risk is elevated, in both men and women, until 75 years of 
age (38). As an example, a 20 year-old white man with a BMI of 45 or more is predicted to lose 
13 years of his predicted 78 years of life (39, 40).  
Childhood obesity is associated with numerous risk factors for later heart disease, such as 
hyperlipidaemia, hyperinsulinaemia, atherosclerosis, and hypertension (41). However, it is not 
fully known whether these risk factors operate through the association between child and adult 
obesity or if they act independently (42). Nonetheless, WHO has defined childhood obesity as an 
established major public health problem, stating the importance of the world wide epidemic (23).  
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GWG and obesity 
Excess GWG (as defined by IOM) is a risk factor for short- and long-term post-partum weight 
retention, and thus for overweight and obesity in women (43). Furthermore, maternal obesity and 
excess GWG may have intergenerational effects, via fetal epigenetic programing of metabolic 
function, which may perpetuate obesity in the next generation (44). This vicious circle may have 
serious long-term negative consequences for both mothers and their offspring. It is speculated 
that maternal obesity and excess GWG result in epigenetic modifications, which predict the 
need for efficient fat storage in postnatal life (45, 46). The negative long-term effects on offspring 
of maternal obesity during pregnancy is supported by epidemiological data indicating that 
children born to obese women before maternal bariatric surgery (BMS) are at higher risk of 
obesity than those born after maternal surgery (AMS) (47). Results from the same series of obese 
women undergoing bariatric surgery and their offspring indicate differential methylation 
patterns in glucoregulatory, inflammatory and vascular disease genes in BMS siblings 
compared with AMS siblings (48). Further results emphasizing the importance of the intrauterine 
environment come from survivors of the 1944 Dutch Hunger Winter. Individuals exposed to 
famine when in utero showed a higher incidence of coronary heart disease and dyslipidaemia 
later in life compared with siblings who had grown up under “normal” in utero conditions. The 
same individuals who were prenatally exposed to famine during the 1944 Dutch Hunger Winter 
had, six decades later, less DNA methylation of gene promoter of the imprinted insulin-like 
growth factor 2 gene (IGF2) compared with their unexposed, same-sex siblings (49). Excessive 
fetal growth, from excessive GWG and high dietary fat and sugar intake during pregnancy, 
which may lead to altered glucose metabolism, are associated with intergenerational effects. 
Human studies indicate that excessive fetal growth may predispose offspring to develop 
obesity, T2D and cardiovascular disease (50-52). Further data supporting the effect of fetal 
environment on offspring susceptibility to disease later in life come from studies on epigenetic 
heritability in mice. Expression of the agouti viable yellow (Avy) locus, which is associated 
with a yellow coat and obese phenotype, differ among offspring depending on DNA 
methylation and whether the mother was fed a diet rich in methyl donating compounds (e.g., 
folate), or not (53). This obese phenotype has been shown to be transmitted across two 
subsequent generations (54), and in the third generation only females maintained the obese 
phenotype (55). This finding highlights the possibility of an imprinting mechanism in the 
heritability of obesity, at least in certain species (30). Imprinting is a phenomenon where 
epigenetic markers, such as methylation, affect gene expression according to their maternal or 
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paternal origin (56). Taken together, these data support the hypothesis that changes in the 
availability of nutrients in fetal life may lead to epigenetic changes that are maintained 
throughout life (45). Consequently, there is increasing support in the literature for the need of 
dietary interventions for obese mothers during and perhaps even before pregnancy in order to, 
via possible epigenetic mechanisms, decrease the risk of obesity in offspring (57).     
DNA methylation 
DNA methylation involves covalent attachment of a methyl group to a cytosine at the five-
carbon position of its pyrimidine ring. This occurs primarily in CpG dinucleotides, where a 
cytosine (C) base is positioned adjacent to a guanine (G) base in the DNA sequence. The 
human genome is estimated to contain approximately thirty million CpGs (58), which are 
overrepresented in regions referred as CpG islands, often present in the promoter region of a 
gene (59). Approximately eight to 12% of gene promoters are methylated under normal 
conditions (60). Methylation of the promoter region inhibits the binding of transcription factors, 
and is typically associated with transcriptional inactivation. Furthermore, recent evidence 
suggests that methylation of DNA sequences outside but within a two-kilo base-pair distance of 
a CpG island is associated with transcriptional repression of gene activity (61). In contrast to 
promoter methylation, methylation in the gene body may lead to increased transcriptional 
activity (62). Thus, activation or repression of gene activity is not only dependent on total 
methylation status, but also highly dependent on the specific sites throughout the gene where 
the methylation takes place.   
Genetic and epigenetic control of obesity 
The etiology of obesity is complex, influenced by genetic and epigenetic changes in 
combination with reduced levels of PA and increased consumption of energy-dense foods (63). 
Currently, approximately 150 genetic loci, identified in genome-wide association studies 
(GWAS), are linked to obesity, each accounting for only a small proportion of the predicted 
heritability of obesity. For BMI, the strongest genetic factors that appear in virtually all GWAS 
studies are fat and obesity associated protein (FTO), mealnocortin 4 receptor (MC4R ), and 
transmembrane protein 18 (TMEM18) (63). Approximately two percent of the observed variance 
in BMI can be explained by these loci (64), whereas twin and adoption studies have reported 
45% to 85% heritability of obesity (65). Considering that the proportions of gene variants (single 
nucleotide polymorphism) that have been found to be associated with occurrence of obesity are 
modest, this highlights the question of whether some of familiar aggregation as well as many of 
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the effects of environmental exposures on weight differences may reflect epigenetic processes. 
Epigenetic mechanisms can, via alterations in gene expression, predispose individuals to a 
particular phenotype, which is more or less susceptible to gains in fat mass. These mechanisms 
can operate in fetal life, early childhood, and also throughout adult life (66). In short, the 
increases in obesity over the past decades (17) can potentially be explained by genetic and 
epigenetic changes to the genome, together with reduced levels of PA and increased 
consumption of energy-dense foods, causing an energy imbalance (63).   
It is speculated that environmental factors can alter the epigenetic regulation of genes involved 
in appetite regulation, thereby increasing the risk of development of obesity among individuals 
with an obesogenic genotype (67). Leptin is a central hormone of importance for appetite 
regulation and metabolism control, which is positively correlated with increased body fat 
deposits in humans (68). It has been speculated that the degree of methylation in specific 
promoter regions of the leptin gene could be used as epigenetic biomarkers for a tendency to 
respond with advantageous (less obesogenic) epigenetic regulation of the leptin gene from a 
low calorie diet (69). Another gene associated with obesity and important for appetite regulation 
is the MC4R gene, which has been shown to be hypomethylated in the promoter region, leading 
to increased gene expression, and consequently increased appetite and feeding behavior, in 
mice given a high-fat diet (70). However, the exact mechanism and impact on obesity of the 
genes involved in appetite regulation are not known (30, 71).   
Nutritional compounds may modify expression of genes involved in the development of 
obesity through epigenetic mechanisms such as DNA methylation (72). Lomba et al. found that a 
high-fat diet given to rats is associated with subsequent weight gain and altered DNA 
methylation patterns in genes involved in the development of obesity, e.g., fatty acid synthase 
which is a gene coding for a key enzyme involved in lipogenesis (73). Thus, a high-fat diet may 
effect the expression of obesogenic genes, which are regulated by epigenetic mechanisms, 
thereby increasing the risk of developing obesity (74).   
Low-grade systemic inflammation is associated with excessive adiposity, and may be subject to 
epigenetic influences (75). However, it is not known whether the excessive adiposity is either 
cause or consequence of a chronically inflamed state (76). Diets giving rise to an energy 
deficiency are associated with altered methylation patterns in the genes involved in 
inflammatory pathways (77), and severe systemic inflammation is associated with epigenetic 
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alterations in pro-inflammatory genes (78). In short, several inflammatory genes are under the 
epigenetic control of gene activity.  
Physical activity and obesity 
The dramatic increase in obesity worldwide during the past decades is associated with, and has 
been partly ascribed to, lower levels of PA (79). Furthermore, clinical practice today for obesity 
treatment and long-term weight management includes PA counseling (80). Higher levels of PA 
should be an integrated part of any treatment plan for obese individuals regardless of weight 
loss goals since high levels of PA are inversely associated with cardiovascular disease, T2D 
and all-cause mortality (81). In fact, numerous epidemiological studies suggest that high levels 
of PA attenuate the health risk of obesity (82-84), although the likelihood of having high PA and 
high fitness is to a great extent influenced by BMI. A study by Duncan et al. (85) showed that 
only nine percent of obese individuals had high cardiorespiratory fitness, whereas 17% of 
overweight and 30% of normal-weight individuals showed similarly high levels of fitness.    
Physical activity recommendations 
The current American College of Sports Medicine (ACSM) recommendations for PA to 
maintain health (86) and promote weight loss (87) are summarized in Table 3. The intensity of PA 
should be at least MVPA, performed in bouts of at least 10 minutes duration (88).   
Table 3. American College of Sports Medicine recommendations for physical activity 
Recommendations for Physical Activity Minutes per week in MVPA 10 min-bouts 
Maintaining and improving health At least 150 
Prevention of weight gain 150 - 250 
Promotion of clinically significant weight loss 225 - 420 
Prevention of weight gain after weight loss 200 - 300 
Physical activity and weight change 
Weight change is affected by the amount of energy expended versus the amount of energy 
consumed (89). There is evidence that high levels of PA can attenuate weight gain in people at 
risk of obesity (90). Weight loss interventions, involving increased PA and exercise training 
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programs without a dietary plan, produce, on average, a modest weight loss of two kilograms 
according to Donnelly and colleagues (87).  
Objectively measured cross-sectional data support strong associations between lower levels of 
PA and higher risks of obesity in children, adolescents and adults (91, 92). However, the cross-
sectional study design makes it impossible to draw conclusion about causality. There is 
currently no firm evidence for any longitudinal association between PA and the risk of 
developing obesity (93, 94). Most previous longitudinal observational and intervention studies 
assess PA by questionnaires or interviews that are susceptible to misclassification and recall 
bias (95). In short, PA at baseline is not a strong predictor of weight change in children, 
adolescents or adults. However, high levels of PA are consistently and strongly associated with 
several positive health outcomes, such as beneficial changes in, for example, cholesterol (96), 
and interventions including exercise training programs to promote PA confer health benefits on 
overweight individuals even in the absence of weight loss (97, 98). Thus, high levels of PA should 
be promoted for public health, although the impact of PA on weight change should not be 
exaggerated.   
As indicated in ACSM recommendations for PA (Table 3), obese individuals require a 
substantial amount of PA to maintain their weight after successful weight loss (87). 
Unfortunately, research on weight regain after subsequent weight loss mostly relies on 
observational studies using retrospective data (99). However, some studies of weight regain with 
data on PA are worth mentioning. Andersen et al. (100) monitored weight and PA at one year 
follow-up after an intervention weight loss study extending over 16 weeks. Two different 
groups were evaluated with a low fat diet and exercise training program, and a low-fat diet and 
“regular” PA counseling. After 16 weeks of intervention, both groups lost approximately eight 
kilograms in weight. At one-year follow-up, people who were the most active (exercise training 
program) lost an additional 1.9 kg, whereas the less active group regained 4.9 kg. Another 
study of weight maintenance observed a dose-response association between the amount of self-
reported PA and success with weight loss at 18 months after an intervention comprising caloric 
restriction and exercise training. Participants who exercised more than 200 minutes per week 
lost more weight (-13.1 kg) than those who exercised less than 150 minutes per week (-3.5 kg) 
(101). Lastly, Jakicic et al. (102) observed similar findings in a 12-week long intervention 
comprising caloric restriction and exercise training in women. At 12-month follow-up, women 
who exercised more than 200 minutes per week had maintained a significantly greater 
percentage of their weight loss (13.6%) compared with those who had exercised less than 150 
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minutes per week (4.7%). A recent review exploring the effects on long-term weight loss and 
risk of chronic-disease risk factors when diet is combined with exercise, compared with either 
diet or exercise alone, found no advantage in minimizing weight regain for any weight loss 
method (103). In summary, PA may have a role in preventing weight regain after successful 
weight loss from interventions including high levels of PA and caloric restriction, although the 
effect of PA on minimizing weight regain should not be exaggerated.  
 
1.3 BARIATRIC SURGERY 
The American Heart Association’s scientific statement on obesity and weight loss recommends 
weight loss in obese patients to reduce several obesity-related co-morbidities and increase 
longevity (104). Unfortunately, traditional weight loss regimes, based on dietary restrictions and 
PA counseling, have modest long-term effects (105). With these facts in mind, it is not surprising 
that the use of bariatric surgery has increased sharply in the last few decades. The number of 
patients treated for severe obesity by surgery in Sweden has increased from 790 in 1997 to over 
7900 in 2012 (106). Laparoscopic Roux-en-Y Gastric Bypass (RYGB) has been standardized in 
Sweden (107), and accounts for approximately 92% of all bariatric surgery carried out in Sweden 
today (106). The laparoscopic approach reduces the risk of 30-day in-hospital morbidity and 
mortality compared with open surgery, and is further associated with shorter in-hospital stays 
(108).  
Indications 
Swedish recommendations for bariatric surgery are for people with BMI of 35 or more, with or 
without co-morbidity (109). The patient should have made serious attempts to lose excess weight 
prior to primary bariatric surgery. Surgery is performed in the age span 18 to 60 years, although 
there are exceptions. Patients under the age of 18 may be treated by surgery if they are enrolled 
on a scientific program, and in patients over the age of 60 a risk-benefit evaluation is of 
importance (109, 110). Contraindications for bariatric surgery include non-compliant patients with 
cognitive or mental disorders, alcohol or drug abuse or severe mental illness (111). Although 
obesity prevalence in Sweden is fairly equally prevalent in men and women (17), approximately 
70% of bariatric surgery candidates are women (106). This may reflect society’s views on obesity 
differing according to gender (112).   
Surgical methods 
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The currently used bariatric surgery procedures can be divided into restrictive and gut peptide 
altering surgery (113). Some examples of restrictive procedures are horizontal gastroplasty (1), 
vertical banded gastroplasty (2) and gastric banding (4), while examples of gut peptide altering 
procedures are RYGB (3) and Jejunoileal bypass (5). 
Figure 1. Examples of bariatric surgery procedures 
   
              1                        2             3                    4                             5 
Complications after surgery 
Examples of general post-surgery complications are gastric leak, bleedings, internal hernias, 
and dumping syndrome (RYGB) (114). Furthermore, nutritional deficiencies, which are more 
common after gut peptide altering compared with restrictive procedures, may follow bariatric 
surgery (115). The post-surgery mortality risk is generally low after bariatric surgery. According 
to the Scandinavian Obesity Surgery Registry, which has been linked to the Swedish total 
population register, 30-day and 90-day mortality between 2007 and 2012 were 0.05% and 
0.08%, respectively (106).  
Weight outcome after bariatric surgery 
The general criterion for successful bariatric surgery is set at 50% or more excess weight loss 
sustained for five years after surgery (excess weight equals total pre-surgery weight minus ideal 
weight) (116). A Cochrane review from 2009 showed that two-year follow-up weight loss was 
greater following RYGB compared with vertical banded gastroplasty and adjusted gastric 
banding (117). The Swedish Obese Subjects (SOS) study shows a maximum weight loss, one to 
two years after surgery, of 32% in RYGB, 25% in vertical banding, and 20% in gastric banding 
(118). In the SOS study 13% of all surgical procedures were RYGB and the mean post-surgery 
weight losses after 10, 15 and 20 years were 17%, 16% and 18%, respectively (119). However, 
data from the Scandinavian Obesity Surgery Registry shows that all surgical procedures are 
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associated with a slight weight regain (approximately 5%), which often occurs between two 
and five years post-surgery (106).       
 
1.4 BEFORE AND AFTER BARIATRIC SURGERY 
1.4.1 Gestational weight gain and offspring weight 
Weight-loss before conception is an effective way of reducing the risk of obstetric 
complications in women. Thus, bariatric surgery has become an important alternative for obese 
women planning pregnancy (120). Studies that have examined pregnancy outcomes after 
bariatric surgery have reported lower rates of adverse perinatal outcomes after surgery (121), and 
similar outcomes for the different procedures (122).  Moreover, compared with obese women not 
undergoing bariatric surgery, the risk of obesity-related gestational complications decreased 
significantly after bariatric surgery (123). However, data on GWG and offspring weight 
development in early childhood based on paired pregnancies with siblings born before and after 
bariatric surgery are sparse. Aricha-Tamir et al. showed similar GWG before (3.9 BMI units) 
and after (3.9 BMI units) bariatric surgery in 144 paired pregnancies. However, offspring birth 
weight was significantly lower after bariatric surgery. A study from 2013 with paired data on 
109 women who gave birth before and after bariatric surgery (only restrictive bariatric 
procedures were included) showed similar GWG across three pregnancies, while offspring birth 
weight was significantly lower in the two pregnancies subsequent to bariatric surgery compared 
with offspring birth weight before surgery (124). Although parity is a risk factor for weight gain 
and visceral obesity (125), the women had essentially the same pre-pregnancy BMI and GWG in 
both pregnancies following surgery. Bearing in mind the fact that women retain significant 
weight postpartum (125), contributing to the vicious circle of obesity, it is of importance that 
women undergoing bariatric surgery do not gain weight between pregnancies following 
bariatric surgery (124).  
 
1.4.2 Physical activity 
The vast majority of bariatric surgery candidates are known to engage in low levels of PA (126), 
and fail to increase objectively measured PA post-surgery despite substantial weight loss (127, 
128). On the contrary, subjectively measured PA increase after surgery (129-131), which clearly 
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reflects the problem of the over-reporting of self-reported PA among obese individuals (132). 
Moreover, time spent sedentary (133) and PA through the activities of daily living (e.g., house-
work) have been shown to be more difficult to accurately recall compared with planned 
exercise (134). This is of concern since PA among bariatric surgery candidates mostly derives 
from daily living and not planned exercise (135). Previous studies, assessing pre- to post-bariatric 
surgery changes in objectively measured PA, have used pedometers or accelerometers, to 
assess PA after surgery (128) (127). A recent study of 40 patients used the Sense Wear Armband 
and the Step Watch Activity Monitor when assessing PA and SB six to 18 months after 
bariatric surgery. Based on accelerometer data, the study reported that patients spend more than 
70% of their waking time in SB, and as little as five percent in MVPA. However, in an 
assessment based on average daily step counts form pedometers, 39% (9108 SD 4360 steps per 
day) of patents were classified as active (136). Nevertheless, almost all current results on 
objectively measured PA after bariatric surgery (127, 128, 136) indicate that post-surgery PA levels 
following bariatric surgery may not be sufficient to optimize weight loss and prevent weight 
regain over time (86, 87).   
 
1.4.3 Epigenetics 
Bariatric surgery, especially RYGB, dramatically improves insulin sensitivity and may lead to 
the clinical remission of T2D, often before weight loss has occurred (137). Epigenetic regulation 
via DNA methylation has been suggested to regulate the activity of genes involved in metabolic 
regulation in T2D (138), and change in DNA methylation at specific sites within a gene may be 
one of the underlying mechanisms contributing to rapid metabolic improvements after RYGB. 
Barres and colleagues have reported differences in DNA methylation within the promoter 
region of genes peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-
1α) and pyruvate dehydrogenase lipoamide kinase isozyme 4 (PDK4), which are involved in 
the regulation of lipid metabolism and associated with improvements in insulin sensitivity and 
weight loss following RYGB (139). RYGB but not caloric restriction alone, results in alterations 
in the promoter methylation of genes involved in inflammation and metabolic regulation, such 
as PDK4, interleukin 1 (IL1), interleukin 6 (IL6) and tumor necrosis factor (TNF). Thus, 
alterations in promoter specific methylation following RYGB may be elicited by factors other 
than mere caloric restriction (140).  
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Maternal obesity and diet in pregnancy may impact on epigenetic control, via regulation of the 
accessibility of the transcription machinery to the chromatin, and may predispose offspring to a 
particular phenotype, which may be or less susceptible to gains in fat mass and the 
development of T2D (66). The large weight loss that often follows bariatric surgery may 
contribute to the exposure of a fetus to a less obesogenic intrauterine environment, which may 
decrease the risk of obesity in offspring by epigenetic mechanisms (141). Previous studies have 
shown that children born after biliopancreatic diversion (BPD) have a lower prevalence of 
obesity (47), greater insulin sensitivity, and an improved lipid profile (142) in comparison with 
children born before maternal BPD. By contrast, other researchers failed to detect an effect of 
bariatric surgery on weight development in offspring in an analysis of 164 children born before 
and 176 children born after maternal surgery (143). The discrepancies seen in offspring BMI 
after bariatric surgery in studies by Kral et al. and Willmer et al. may be due to different 
surgical methods used in the two studies (BPD compared with mostly restrictive surgery) with 
different effects on both post-surgery weight loss and other biological aspects such as the 
epigenetic regulation of gene activity (144).   
Bariatric surgery has been shown to have an impact on the methylation levels of genes in 
glucose regulation, immune response and inflammatory signaling in comparison with BMS and 
AMS siblings (48, 145). Moreover, a pilot study from 2011 that focused on epigenetic analyses, 
using whole blood in patients undergoing RYGB, showed changes in the gene expression of 
T2D and obesity-related pathways (146). Collectively, these results demonstrate powerful effects 
of RYGB and BPD on the epigenetic and transcriptional levels of the genes involved in 
inflammation and metabolism, both in patients undergoing surgery and in offspring born after 
maternal surgery.   
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2 AIMS OF THE STUDIES 
The overall aim was to (i) investigate the possible effects of maternal weight loss after bariatric 
surgery, and the effects of differences in maternal gestational weight gain in repeated 
pregnancies of the same women on sibling body size in childhood, epigenetic profile and (ii) to 
objectively characterize physical activity and sedentary behavior among women, children and 
spouses, before and after maternal Roux-en-Y gastric bypass surgery. 
Specific research questions: 
• Are differences in maternal gestational weight gain in repeated pregnancies of the same 
women before and after bariatric surgery associated with differences in offspring birth 
weight and BMI at four and six years of age? (Study one) 
 
• Are there epigenetic methylation differences in obesity-related genes between siblings 
born before and after maternal weight loss after bariatric surgery? (Study two) 
 
• Are obese women treated by Roux-en-Y gastric bypass who lose a large amount of 
weight more physically active nine months after surgery? (Study three)   
 
• Are the children and spouses of  obese women treated by Roux-en-Y gastric bypass 
who lose a large amount of weight more physically active nine months after surgery? 
(Study four)   
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3 MATERIAL AND METHODS 
3.1 DATA COLLECTION ONE 
Data collection one was used for studies one and four. 
Data-registers  
The personal identification number (ID) unique to each Swedish resident enabled us to create a 
database by record linkage between the Swedish Medical Birth Register, which covers 99% of 
all births in Sweden (147), the Hospital Discharge Register, the Cause of Death Register ,which 
contains information about all bariatric operations performed in Sweden, the Cancer Register, 
and the Register of the Total Population, which contains data on all current residents in 
Sweden.  
The data set finally comprised 797 women who had undergone bariatric surgery between 1980 
and 2006, and had given birth both before and after surgery. All 797 women received an 
information letter by mail, and were then contacted by telephone. The women who wished to 
participate and their adult children signed a general consent form and a specific form that 
allowed our team to collect information from the registers described above (including ID 
numbers). 
Data collection on GWG and offspring weight 
We then collected measured data from hospital archives on the women’s BMI from first 
antenatal visit (approximately in gestational week ten) and throughout pregnancy, and about 
complications during pregnancy. Moreover, we collected data on BMI at the time of their 
bariatric surgery, and all available follow-up BMI data. For children, we collected growth 
charts from birth to six years of age from child health centers, school health services, and 
county council and municipal archives. In total, we collected GWG and birth-weight data on 
124 women and their 124 offspring sibling-pairs (248 siblings in total), and also measured data 
on height and weight from birth to six years of age for 39 offspring sibling-pairs (Figure 2).  
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Figure 2. Overview of the data collection one procedure 
 
Furthermore, we collected information from medical birth records, which contained the 
following data: maternal age, weight, height, gestational week, parity, offspring birth weight 
and length, gestational diabetes, pre-eclampsia, breast-feeding, and smoking status. 
Blood collection 
The 124 women and their offspring were contacted via telephone and mail and asked to visit 
their nearest health center for their blood (2 x 5ml) to be collected. Blood samples were 
collected during an overnight fast from an antecubital vein into tubes containing EDTA 
(Qiagen). The final study sample (comprising women who had lost at least one BMI unit 
between pregnancies) encompassed blood samples from 31 women with offspring born before 
and after their mothers’ bariatric surgery (62 siblings). The blood collection followed standard 
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procedures, and the collected blood was sent for storage at -80° to the biobank held by 
Karolinska Institutet.  
DNA methylation analysis 
Recent technological advances have made it possible to map DNA methylation genome-wide, 
at high resolution in large samples (148). The recent and rapidly growing field of epigenetic 
epidemiology (149) has made it possible to map DNA methylation patterns in large cohorts. This 
type of study is referred to as an epigenome-wide association study (EWAS), which requires 
robust normalization algorithms for microarray-based DNA methylation data and rigid 
statistical tests for the identification of differently methylated sites (DMS) between exposed 
and unexposed subjects (150).  
There are several experimental methods developed for genome-wide DNA methylation 
mapping (148). The most accurate method known today is high-throughput methylome 
sequencing, which cover the whole genome at a single base resolution. However, this method is 
extremely costly and time-consuming, which is why array-based methods (assembly of 
microscopic DNA segments attached to a solid surface) have become increasingly popular for 
use in EWAS studies (151). For the epigenetic methylation analyses of obesity-related genes in 
Study two, the most frequently used array-based method was used, namely Illumina Human 
Methylation 450 Bead Chip platform, which quantifies DNA methylation levels in slightly 
more than 485.000 regions (96%) of DNA where a cytosine nucleotide occurs next to a guanine 
nucleotide (CpGs). There array covers an average of 17 CpG sites per gene region in 99% of 
known genes throughout the whole genome (152).  
The method is based on bisulfate conversion where an epigenetic code (methylation) is 
translated into a genetic code by conversion of unmethylated cytosine residues into uracil while 
leaving methylated cytosine unaltered, which enables detection of methylation levels through 
DNA sequencing techniques. The Illumina Human Methylation 450 Bead Chip platform uses 
two different probe types (fragment of DNA used to detect the presence of nucleotide 
sequences) to distinguish between methylated and unmethylated DNA. Using two probe types, 
binding to different sites within methylated and unmethylated DNA, enables coverage of large 
parts of the human genome. However, the two different probe types have slightly different 
distributions. Therefore, normalization, by adjusting values measured on different scales to a 
general common scale, is necessary (153). A recent study showed that more sophisticated 
normalization by Beta-mixture Quantile dilation might improve data quality and reduce signal 
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bias between the two probe types (154). The normalization subtracts background noise and uses a 
positive (100% methylation) and a negative (no methylation) control probe. The main results of 
the normalization process are a table of b-values, an alternative term for the absolute DNA 
methylation levels. The b-value is often transformed into a M-value, which is a logistically 
transformed b-value used in several common statistical tests (155).   
The most common goal of DNA methylation mapping is to identify systematic differences 
between groups of samples, such as BMS and AMS siblings in our study. Next, the typical step 
is to identify DMS between sample groups. It is widely known that DMS can control cell-type 
specific transcription of a gene (156). However, it is difficult to assess the practical influences of 
susceptibility to disease from observed differences in methylation patterns in specific regions of 
a gene. Therefore, researchers often apply gene set pathway analysis tools to identify 
biologically meaningful effects from differently methylated regions in genes (157).  
Ethical committee approval was obtained from the Stockholm Regional Ethical Review Board 
(no. 2009/709-31/2). 
3.2 DATA COLLECTION TWO 
Data collection two was used for studies three and four. 
Participants 
We recruited women living with or without a spouse, with children between the ages seven 
to14 years on RYGB-surgery waiting lists (primary bariatric surgery) at five Swedish hospitals; 
Danderyd Hospital, Ersta Hospital, Uppsala University Hospital, Örebro University Hospital, 
and St:Görans Hospital. The women underwent laparoscopic RYGB surgery between June 
2012 and January 2013. We were able to recruit 69 families for the study where 56 women 
(81%) had data on PA both pre- and post-surgery. Only families where the women undergoing 
RYGB had PA data before and after surgery were included in Study four. Baseline descriptive 
(e.g., BMI) in families (before and after maternal surgery) with complete PA data did not differ 
significantly from those with incomplete data.   
A research visit was made by the current and a fellow PhD student (Mikaela Willmer) to the 
participants’ homes three months before and nine months after maternal RYGB surgery in 
order to limit seasonal effects on PA and SB (one year between measurements). The mean time 
interval between pre- and post-surgery assessments was 12.8 (SD 2.3) months.  
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For Study three, we analyzed 56 women, while, for Study four, the final study sample 
encompassed 56 families, comprising 56 women, 33 spouses, and 75 children between the ages 
seven and 14 years. Of 69 recruited families, 13 (16%) had incomplete PA data before and after 
maternal surgery and five families (7%) were lost at the follow-up measurement nine months 
after surgery for different reasons (e.g., lack of time or interest to participate).  
Figure 3. Overview of data collection two 
 
Anthropometrics  
Anthropometric measures were taken in the participants’ home using high quality and 
calibrated electronic scales for weighing and a stadiometer for the measurement of height. The 
two PhD students took all measures at both research visits. Fat free mass (FFM) and fat mass 
(FM) were derived from bioelectric impedance analysis (BIA) (Quantum II, RJL Systems, 
Clinton Township, MI, USA), and were calculated using an equation by Kyle et al. (158).  
Physical activity assessment  
PA was measured using the Actigraph GT3X+ monitor (Pensacola, FL), a tri-axial 
accelerometer assessing acceleration on the vertical, antero-posterior, and medio-lateral axes. 
We analyzed vector magnitude (Vm) activity counts, calculated as the square root of the sum of 
the three axes. The GT3X+ accelerometer is a valid tool for estimating PA and most types of 
human daily activities (159).  
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Participants were asked to wear the monitor at their right hip during all waking hours for seven 
consecutive days. To further increase compliance, three standardized text messages were sent 
to the participants’ cell phones during the seven-day measurement period. The number of high-
intensity minutes occurring in bouts of 10 minutes or more was computed by using an 
algorithm developed by Choi et al. (160), while non-wear time was defined as 60 minutes of 
consecutive zero recordings, allowing for two minutes of non-zero interruptions (161). Bouts and 
wear time were computed using R-packages: PhysicalActivity and ‘Accelerometry.  All 
participants with at least ten hours per day of monitor wear time for three days or more (128) at 
both the before and after maternal surgery assessments were included in the analyses. There is 
evidence in the literature of the use of age specific cut-offs to assess different levels of PA (162). 
Hence, for our analyses we chose to use cut-offs based on the validation studies of Santos-
Lozano (163) et al. and Hanggi et al. (164), since the study populations used in those studies 
matched our study population with regard to age (Table 4).  
Table 4. The accelerometer cut-offs for GT3X+, expressed as counts per minute (cpm), used in 
studies three and four 
Adults Santos-Lozano et al. (163) Children Hanggi et al. (164) 
SB < 100 cpm SB < 180 cpm 
LPA 101 - 3208 cpm LPA 180 - 3360 cpm 
MVPA > 3208 cpm MVPA > 3360 cpm 
Ethical committee approval was given by the Stockholm Regional Ethical Review Board (no. 
2009/1472-31/3). 
 
3.3 OVERVIEW OF THE DATA COLLECTION 
 
Table 5. Overview of the data collections that took place between the years 2010 and 2014  
Data collection Study 
(1-4) 
2010  2011 2012 2013 2014 
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Contacting 797 women and offspring sibling-pairs via 
telephone and letter 
1 and 2 
X X    
Collecting antenatal medical records for 348 women 
and growth charts from offspring sibling-pairs 
1 and 2 
 X X   
Collecting blood samples from 124 women and 
offspring sibling-pairs 
1 and 2 
 X X X  
Recruiting 69 women with family members from 5 
different hospitals 
3 and 4 
  X X  
Research-visit in home environment in 69 families 
before and after maternal Roux-en-Y Gastric Bypass 
3 and 4 
  X X X 
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4 OVERVIEW OF THE FOUR STUDIES 
Table 6. Overview of the characteristics of studies one to four  
 Study one Study two Study three Study four 
Design Longitudinal study 
mainly based on 
existing routine 
data in archives 
Longitudinal study 
with retrospective 
data and blood 
samples 
Prospective 
longitudinal study 
Prospective 
longitudinal study 
Participants 124 women, 248 
sibling-pairs, 39 
sibling-pairs with 
BMI at 4 and 6 
years 
31 sibling-pairs 
(62 siblings) 
56 women 
undergoing RYGB 
56 Families: 56 
women, 33 
spouses, and 75 
children 
Methods Measured 
objective data 
from medical 
journals and 
growth charts 
Measured 
objective data 
from medical 
journals and 
growth charts. 
Epigenetic data 
from Illumina 450k 
analyses 
Accelerometer 
data (GT3X+) and 
objectively 
measured 
anthropometrics 
Accelerometer 
data (GT3X+) and 
objectively 
measured 
anthropometrics 
Data  Objective data 
(secondary data) 
Objective data 
(secondary data 
and self-collected) 
Objective data 
(self-collected) 
Objective data 
(self-collected) 
Outcome 
measures 
Differences in 
GWG, offspring 
birth weight and 
BMI at 4 and 6 
years 
Differences in 
epigenetic 
regulation of 
obesity-related 
genes 
Changes in 
objectively 
measured PA and 
SB 
Changes in 
objectively 
measured PA and 
SB 
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Statistical 
analyses 
Mixed linear 
models, fixed 
effect regression 
Paired t-tests, 
McNemar’s tests 
Linear regression, 
fixed effect 
regression, paired 
t-tests, McNemar’s 
tests 
Linear regression, 
fixed effect 
regression, paired 
t-tests, McNemar’s 
tests 
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5 STATISTICAL ANALYSIS 
 
All statistical analyses for papers one to four were performed with STATA versions 12.1 and 
13.1 (STATA Corp, College Station, Texas, USA) software. 
We used data from subjects who were repeatedly measured over time in studies with a 
longitudinal design. Statistical analyses for such a study design must take into account that data 
from an individual at different times are very unlikely to be independent, and most likely are 
correlated. If correlation is ignored, it may negatively impact on parameter estimation, 
hypothesis testing, and the efficacy of the study design (165). There are several issues when 
conducting statistical analyses of longitudinal data, such as correlation between repeated 
outcome measurements, missing data, irregularly timed data, and a mixture of static and time-
varying covariates (the word covariate is sometimes used synonymously with independent 
variable, predictor variable, explanatory variable, and risk facts).    
 
5.1 STUDY ONE 
In Study one we used a mixed model (“xtmixed” command in STATA) that primarily focuses 
on relationships restricted to observations at individual level. The mixed model is used when 
modeling a continuous outcome measure as a function of fixed effects while simultaneously 
modeling individual parameters as random effects. Hence, the mixed model can handle both 
time-dependent and static covariates (166). Fixed effect describes the impact of known covariates 
(e.g., genetic factors) and is assumed to be constant between measurement points. Random 
effect measures the impact of known variables where effects are assumed to vary within the 
study population (e.g., environmental factors). We used the mixed model in Study one to 
estimate the extent to which associations, between differences in GWG and differences in birth 
weight and BMI at four and six years, were driven by shared genetic and lifestyle factors (fixed 
effects) or by non-shared factors (between effects).   
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5.2 STUDY TWO  
In Study two the data were expressed as means ± SD for unadjusted values, and the differences 
in descriptive characteristics in mothers and BMS and AMS siblings were assessed using a 
within-subject paired t-test for continuous variables and McNemar’s test for dichotomous 
variables.  Since BMI was rarely measured at exactly four years of age, we predicted BMI at 
four and six years, and also maternal pre-pregnancy weight and GWG using a non-parametric 
regression method, so-called kernel smoothing (167), with the “lokern” package in R-software 
(http://www.r-project.org). 
  
Epigenetic analyses 
GenomeStudio software version 2011.1 (Illumina Inc.) was used for processing epigenetic 
methylation data. All samples were adjusted for color bias and normalized using Quantile 
normalization method using the Lumi  package in R Bioconductor 
(http://www.bioconductor.org). The Illumina 450k methylation array uses two different probe 
types  (Infinitum one and two) with different characteristics (colors red and green), thus 
requiring cautious normalization to reduce technical bias (153). We used BMIQ normalization as 
proposed by Marabita F et al. to improve data quality and reduce technical variation (154).  
Methylation levels (b-values) were estimated as the ratios of the signal intensity of the 
methylated alleles to the sum of methylated and unmethylated intensity signals. The b-values 
vary from zero (no methylation) to one (100% methylation). Log2 ratios known as M-values 
were generated and were used for further analysis. Sites with a p-value of 0.05 or more were 
removed and not analyzed further. Differences in M-value between groups (<0.5 or >0.5) were 
taken as significant differences in methylation, and used as the main statistical results for 
comparison between BMS and AMS siblings (155). 
  
We used the ingenuity pathway analysis (IPA) platform to analyze potentially altered gene 
functions and pathways between BMS and AMS siblings. Results from the differential 
methylation analysis provided a list of probes with significant DMS and corresponding gene 
identification numbers. Differently methylated probes present at CpG sites with the highest 
DMS were selected, and thereafter used in an IPA analysis. IPA measures the likelihood that 
these genes participate in a particular function or pathway, and calculates a p-value using right-
tailed Fisher’s exact test for each unique pathway and gene function.   
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5.3 STUDIES THREE AND FOUR 
In studies three and four we used linear regression to estimate associations between baseline 
PA, SB and anthropometric measures, with post-surgery PA and SB, and pre- to post-surgery 
change in PA as outcomes. Furthermore, we created difference variables (post-surgery minus 
pre-surgery) for PA, SB and the anthropometric measures, which enabled us to control for all 
effects that are constant (e.g., genetic factors) from before to after surgery (fixed-effects 
regression). Thus, we conducted a linear regression on differences in several variables from 
three months pre- to nine months post-surgery. To account for slight deviations from the 
normal distribution, we used robust standard errors to estimate confidence intervals. As well as 
using robust variance, also ran robust regression models (STATA command ‘rreg’) to see 
whether outliers had any impact on the results. However, the results remained stable and did 
not change any of the conclusions drawn in Study three or Study four.    
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6 RESULTS 
6.1 STUDY ONE 
We used a sibling-pair design to examine the associations of differences in total and trimester 
specific GWG in repeated pregnancies of the same woman (n = 124), before and after bariatric 
surgery, with differences in offspring birth weight and BMI at four and six years of age.  
Figure 4. Schematic overview of the design of Study one 
 
The main findings in this study were that there were positive associations, in women 
undergoing bariatric surgery, between differences in total GWG and GWG in the second 
trimester and differences in offspring birth weight when maternal characteristics (e.g., genetic 
factors), fixed from one pregnancy to a later pregnancy, were taken into account. Furthermore, 
women undergoing bariatric surgery had lower GWG before surgery, at 11.3 (SD 7.2), 
compared with after surgery, at 8.3 (6.4), giving a p-value of less than 0.001. Time between 
pregnancy and bariatric surgery was 4.1 years (SD 2.7 years) with a range 0.7 to 12.8 years, 
and 3.7 years (SD 2.3 years) with a range 0.9 to11.5 years, before and after surgery, 
respectively. 
 
After adjusting for pre-pregnancy BMI, we found that the greater differences in total GWG and 
GWG in the second trimester were associated with increased differences in birth weight both 
  31 
within siblings and between non-siblings: for total GWG within siblings, a 0.041 standard 
deviation score (SDS) (one birth-weight SDS score corresponds to approximately 0.55 kg or 
1.43 BMI units) per 1-kg increase in weight (95% CI, 0.014, 0.069), and for the second 
trimester a 0.96 SDS for each 1-kg greater weight change per week (95% CI, 0.32, 1.61). The 
associations within siblings and between non-siblings did not differ from each other (p = 0.81 
and p = 0.79, respectively) (Table 7).  
Table 7. Within-pair and between-pairs effects of 1-kg greater gestational weight gain and mean 
growth rate (kg/week) during each trimester on child’s birth weight (n=124) 
 
Total gestational 
weight gain 
(GWG) 
Mean increase in 
kg/week during 
trimester 1 
Mean increase in 
kg/week during 
trimester 2 
Mean increase in 
kg/week during 
trimester 3 
 
β (95% CI) β (95% CI) β (95% CI) β (95% CI) 
Model 2 (adjusted for maternal age, pre-pregnancy weight and height) 
Within 
0.041 (0.014, 
0.069) 0.44 (-0.085, 0.97) 0.96 (0.32, 1.61) 0.49 (-0.19, 1.17) 
Between 
0.036 (0.0043, 
0.068) 0.32 (-0.38, 1.01) 0.83 (0.068, 1.59) 0.74 (-0.074, 1.56) 
Test for 
differenc
e P=0.81 P=0.78 P=0.79 P=0.65 
 
In contrast to the above, data associations of GWG with differences in offsprings’ BMI SDS at 
birth and at four and six years for a subset of 39 mothers and 78 children with complete data on 
all three occasions were weak and non-significant.  
 
6.2 STUDY TWO 
We used a sibling-pair design to examine the effects of maternal weight loss due to bariatric 
surgery between two pregnancies on methylation levels of genes associated with T2D and 
obesity in comparisons between BMS and AMS siblings. The main findings of this study were 
that maternal bariatric surgery, with subsequent weight loss between pregnancies, was 
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associated with overrepresentation of DMS in the genes involved in cytokine inflammatory 
signaling and T2D signaling pathways. Additionally, we show that the genes involved in T1D, 
T2D and obesity, such as major histocompatibility complex, class II, DQ beta 1 (HLA-DQB1), 
proopiomelanocortin (POMC), IGF2, insulin receptor (INSR), fat mass and obesity associated 
protein (FTO) and TNF are either hypermethylated or hypomethylated when comparing DMS 
between BMS and AMS siblings. A total of 4230 genes, with 27 310 corresponding 
methylation sites, of which 8036 within CpG islands, were differently methylated. 
Furthermore, we found differences in global methylation distribution patterns when comparing 
all siblings born before maternal bariatric surgery with siblings born after gut peptide altering 
maternal surgery and restrictive maternal surgery (Figure 5). Siblings born after maternal 
restrictive surgery exhibited hypermethylation of HLA-DQA1 major histocompatibility 
complex, class II, DQ alpha 1 (HLA-DQA1) and HLA-DQB1 (the two most significantly 
differently methylated genes), by contrast with siblings born after maternal gut peptide altering 
surgery.   
Figure 5. Principal component analysis (PCA) of global methylation patterns in differently 
methylated genes of all siblings born before (n = 31) and siblings born after restrictive maternal 
surgery (n = 21) and siblings born after gut peptide altering maternal surgery (n = 10). Each of 
the circles in the figure represents a sample. The PCA analysis and visualization were performed 
using the Qlucore Omics Explorer. 
 
 
• Siblings born before maternal surgery 
• Siblings born after restrictive maternal surgery 
• Siblings born after gut peptide altering maternal surgery 
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To address the aim of Study two with possible effects on offspring methylome from alterations 
in the maternal intrauterine environment, we selected women who had lost at least one BMI 
unit between pregnancies. This created a somewhat different study population compared with 
that used in Study one (tables 8 and 9).  
Table 8. Descriptive characteristics of women included in studies one and two 
Characteristic Delivery before 
bariatric surgery, 
Study one  (SD) 
Delivery before 
bariatric surgery, 
Study two (SD) 
Delivery after 
bariatric 
surgery, 
Study one  
(SD) 
Delivery after 
bariatric 
surgery, 
Study two 
(SD) 
Maternal age at 
delivery (years) 
25.5 (3.3) 24.2 (2.5) 33.3 (4.3) 32.2 (3.5) 
Maternal BMI in 
gestational week 10 
36.5 (5.0) 38.5 (5.2) 31.2 (6.2) 31.0 (6.5) 
Maternal BMI at birth 40.7 (4.5) 42.6 (5.2) 34.2 (6.3) 34.3 (7.3) 
Total GWG (kg) 11.3 (7.2) 10.6 (8.2) 8.3 (6.4) 9.4 (7.9) 
Birth weight (kg) 3.7 (0.7) 3.8 (0.5) 3.5 (0.6) 3.4 (0.6) 
BMI 4 years 17.4 (2.8) 17.4 (1.7) 18.2 (3.6) 16.7 (1.9) 
BMI 6 years 17.0 (1.8) 18.1 (2.7) 17.7 (2.3) 16.9 (2.2) 
Girl (%) 41.0 41.2 41.0 52.9 
 
Table 9. Differences in surgical procedures and year of surgery for women included in studies 
one and two. 
Surgical procedure Women included in Study one Women included in Study two 
Vetrical banded gastroplasty 
(%) 
39.7 45.0 
Gastric banding (%) 30.0 15.0 
RYGB (%) 13.3 25.0 
Jejunoileal bypass (%) 11.5 9.0 
Horizontal gastroplasty (%) 5.5 6.0 
Mean year for surgery (range) 1994 (1980 - 2006) 1995 (1986 - 2006) 
 
Maternal descriptive characteristics, surgical procedures and the year at which the surgery was 
performed differ between the populations for Study one and Study two. Thus, it is uncertain 
whether the results found in Study four would have been the same if we had used the study 
population in Study one. Moreover, effects other than altered intrauterine environment between 
pregnancies may explain differences in the methylome between BMS and AMS siblings found 
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in Study two. For example, AMS siblings have grown up in a later time period and possibly in 
environments that differed somewhat with regard to eating and physical activity behaviors 
compared with BMS siblings.    
 
6.3 STUDY THREE 
We characterized three months before to nine months after surgery changes in PA and SB in 56 
women undergoing RYGB, using the GT3X+ accelerometer. Additionally, we examined the 
associations between pre- respectively post-surgery PA and SB on anthropometric measures. 
Our main findings indicate no significant differences in MVPA, MVPA in 10-minute bouts, 
LPA or SB from three months before to nine months after surgery in women undergoing 
RYGB, despite substantial weight loss (Table 10).  
Table 10. Changes in PA and SB from three months before to nine months after surgery in 
women undergoing RYGB 
Characteristics Before RYGB 
surgery (SD) 
After RYGB 
surgery (SD) 
Pre- to post-
surgery change 
(SD) 
p-value 
BMI 39.1 (3.2) 27.5 (3.1) -11.7 (2.7) <0.001 
MVPA (min/day) 30.9 (17.7) 32.1 (23.5) 1.2 (22.6) 0.71 
LPA (min/day) 441.0 (92.1) 441.8 (92.5) 0.08 (79.4) 0.99 
SB (min/day) 430.2 (141.5) 420.7 (128.8) -9.5 (129.4) 0.58 
MVPA 10-min bouts 
(min/week) 
65.8 (81.6) 88.9 (116.5) 23.5 (17.1) 0.15 
 
However, women with higher PA before surgery decreased their PA after surgery while women 
with lower PA increased their PA post-surgery. This is illustrated in Figure 6 where pre-surgery 
MVPA shows a negative association with change in MVPA from before to after surgery. 
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Figure 6. Associations between change in MVPA from three months before to nine months after 
surgery and pre-surgery MVPA in women undergoing RYGB 
 
The recommendations in national PA guidelines, accumulating 150 min per week MVPA in 
periods of 10 minutes or more (86), were met by 14.2% of women before and 16.1% after 
RYGB surgery. Depending on the PA intensity, 46.4 to 58.9% of the women decreased their 
PA and 51.8% increased time spent sedentary from before to after RYGB surgery. After 
stratification into two groups, we found that women who increase MVPA from before to after 
RYGB have lower pre-surgery weight, less MVPA minutes per day, and spend more time 
sedentary compared with women who decrease MVPA from before to after surgery. After 
surgery, women who increase MVPA from before to after surgery have lower weight, more 
MVPA minutes per day, and spend less time sedentary compared with women who decrease 
MVPA from before to after RYGB (Table 11).   
 
Table 11. Descriptive characteristics of women who decrease or increase their MVPA from three 
months before to nine months after RYGB 
Characteristics Women who 
increased 
MVPA (n = 29). 
Before RYGB 
(SD) 
Women who 
decreased 
MVPA (n = 27). 
Before RYGB 
(SD) 
Women who 
increased 
MVPA (n = 29). 
After RYGB 
(SD) 
Women who 
decreased 
MVPA (n = 27). 
After RYGB 
(SD) 
-5
0
0
50
10
0
15
0
P
A 
ch
an
ge
0 20 40 60 80 100
Pre-surgery MVPA (min/d)
Predicted regression line + 95% CI
R-squared=11%
 36 
Weight (kg) 107.2 (11.6) 112.3 (10.7) 72.3 (9.3) 80.5 (8.5) 
BMI 39.1 (2.9) 40.2 (2.8) 26.5 (3.0) 28.9 (2.2) 
MVPA (min/day) 27.4 (18.5) 32.8 (14.6) 38.2 (21.8) 19.9 (11.3) 
MVPA 10 min bouts 
(min/week) 
22.7 (28.2) 29.0 (23.5) 38.1 (34.1) 13.5 (11.8) 
LPA (min/day) 440.8 (124.5) 441.4 (94.5) 452.9 (100.8) 432.4 (91.1) 
SB (min/day) 433.8 (124.5) 412.6 (159.5) 406.8 (114.9) 452.3 (140.7) 
We also found a trend (non-significant) towards an overall increase in MVPA in periods of 10 
minutes or more from before to after surgery, suggesting that participants may be able to 
perform work of higher intensity for longer sustained periods of time after RYGB. However, 
there is great variability in changes in PA and SB, and it is important to remember that a large 
proportion of women undergoing RYGB decrease their PA and increase their SB from before 
to after RYGB surgery.   
 
6.4 STUDY FOUR 
We aimed to (i) objectively characterize three months pre- to nine months post-surgery changes 
in the PA and SB of children (seven to 14 years) and spouses of women who have undergone 
RYGB, and (ii) to explore the associations between pre- and post-surgery changes in PA and 
time spent sedentary among family members. The main findings were that objectively 
measured PA three months before and nine months after the women’s RYGB surgery showed 
no significant differences in PA intensity or SB in spouses. However, in children, MVPA and 
LPA decreased significantly, while SB increased significantly, between the before and after 
maternal surgery measurements. There were no significant associations between the women’s 
pre-surgery PA or change in PA and change in PA for spouses or children. Moreover, 43.8% of 
spouses and 38.4% of children decreased time spent on MVPA, and increased SB between the 
before and after maternal RYGB measurements.  
There were no significant pre- to post-surgery differences for MVPA between children or 
spouses who were normal weight, overweight or obese before their mother’s surgery. However, 
there were large variations in pre- and post-surgery PA and SB among children and spouses, 
and also in their differences over time (as illustrated in figures 7 and 8).   
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Figure 7. Change in MVPA and SB in children (n = 75) from three months before to nine months 
after maternal RYGB, stratified according to pre-surgery weight status 
 
 
Figure 8. Change in MVPA and SB in spouses (n = 33) from three months before to nine months 
after maternal RYGB, stratified according to pre-surgery weight status 
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As shown in Table 12, Children under ten years are more active and spend less time sedentary 
compared with children over ten years at both three months before and nine months after 
maternal RYGB. Furthermore, girls are less active compared with boys both before and after 
maternal RYGB. However, it seems that boys increase the time they spend sedentary more than 
girls from before to after maternal RYGB. In fact, boys spend more time sedentary compared 
with girls after maternal RYGB.  
Table 12. Descriptive statistics on children, stratified by age and sex, from three months before 
to nine months after maternal RYGB 
Characteristics Children under 
10 years of age 
(n = 44) (SD) 
Children over 10 
years of age (n = 
31)  (SD) 
Girls all ages (n 
= 37) (SD) 
Boys all ages (n 
= 38) (SD) 
3 months before maternal RYGB surgery 
Weight (kg) 34.6 (7.2) 57.0 (16.6) 41.6 (12.3) 44.0 (18.7) 
BMI 18.9 (2.8) 22.8 (4.4) 20.3 (3.4) 20.5 (4.4) 
MVPA (min/day) 85.5 (41.3) 63.1 (36.0) 62.9 (32.2) 90.3 (44.0) 
MVPA 10min 
bouts (min/week) 
42.4 (33.5) 30.7 (24.6) 26.1 (21.2) 49.3 (34.4) 
LPA (min/day) 486.2 (65.7) 389.1 (78.6) 460.0 (78.6) 437.6 (90.6) 
SB (min/day) 260.0 (110.6) 408.2 (24.6) 322.3 (146.2) 312.5 (142.0) 
9 months after maternal RYGB surgery 
Weight 39.5 (8.9) 61.2 (16.1) 47.6 (12.4) 48.5 (19.1) 
BMI 19.6 (3.2) 23.0 (4.2) 20.9 (3.6) 20.8 (4.4) 
MVPA (min/day) 74.3 (32.2) 52.6 (25.7) 56.5 (25.8) 75.2 (34.1) 
MVPA 10min 
bouts (min/week) 
36.0 (25.6) 24.3 (17.0) 23.4 (15.7) 39.3 (26.3)  
LPA (min/day) 447.9 (70.4) 365.2 (83.1) 435.5 (89.8) 396.9 (77.1) 
SB (min/day) 322.2 (131.7) 446.9 (156.0) 332.5 (107.9) 407.3 (181.0) 
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7 DISCUSSION 
 
7.1 METHODOLOGICAL CONSIDERATIONS 
The different study designs used in the four studies are shown in Table 6. In all four studies 
cohorts of individuals were followed or traced over a period of time (168). The longitudinal study 
design can establish the temporal order of events and sometimes allow causal interpretation of 
results, which is not possible when cross-sectional study design is used (169). In studies one and 
two, most primary data were collected and registered in the past, and collected ad hoc in 
present time from routine information sources, which make these studies historical (or 
retrospective) cohort studies. However, the methylation data used for Study two is primary data 
collected for this specific study. The objective nature of data for all four studies eliminated 
potential recall bias (for studies one and two), which is often seen in studies where the study 
subjects report events from the past (169). Nevertheless, we may have introduced selection bias 
as people who are more positive to participate in research may have agreed to participate in the 
two data collections to a greater extent than people who have a negative attitude towards 
participating in research.   
 
7.1.1 Data collection one 
Since Sweden has a long tradition of well-kept registers in combination with the personal 
identification number, we were able to find a large proportion of women who had undergone 
bariatric surgery between the years 1980 and 2006, and had given birth both before and after 
surgery. Unfortunately, we were unable to obtain information on all available women since 
some archives had taken out some of the medical records collected at child care centers. We 
also found it difficult to come into contact with some of the women and their children by 
telephone or mail to ask for their informed consent. Furthermore, 98 women declined 
participation after the initial telephone interview. Perhaps these women were dissatisfied with 
the outcome after bariatric surgery, which may have resulted in a selection bias that potentially 
could affect the results presented in studies one and two. Further selection bias may have 
occurred in Study two where we collected blood from siblings born before or after their 
mother’s bariatric surgery. Siblings did not leave blood for different reasons, e.g., lack of time 
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or interest, or because they were afraid of needles. Thus, we may have ended up with a study 
population subset of women who were relatively more satisfied with post-surgery outcomes 
and in general were positive to participate in research.  
 
Epidemiological wide association studies (EWAS) 
EWAS studies provide new opportunities for understanding associations between epigenetic 
changes in gene activity and several complex diseases. However, the many different techniques 
used for epigenetic analysis together with their somewhat different outputs make it challenging 
to interpret results from EWAS studies.  
Finding an adequate sample size to achieve necessary statistical power to address the specific 
research question is a potential problem in EWAS studies since this is a newly emerging field 
with limited available preliminary data compared with GWAS studies (150). Via array-based 
platforms it is now possible to interpret methylation data from millions of CpGs. Thus, multiple 
comparisons should be accounted for in order to reduce the risk of false positive (type 1 error) 
detections of differences in methylation patterns. One additional fundamental aspect that is of 
importance when interpreting methylation data from EWAS studies is that the studied 
differences in methylation patterns are dynamic by nature and can change over time, compared 
with genomic data that is static (149). Furthermore, it is important to note that the lllumina 
Human Methylation 450 Bead Chip platform used in Study two is not sensitive enough to 
detect all methylation differences. The platform can, approximately, detect differences of 20% 
in methylation with 99% confidence (152).  
There are numerous distinct cell types in the human body, all composed by their identical 
genetic code. All somatic cells in the body have a stable genotype, but the epigenetic pattern of 
a cell and tissue is varied (170, 171). This may have great impact on interpretations of EWAS data 
since some or all observed epigenetic variation in a biologic sample may be attributed to 
differences in cell-type distribution in the sample. Blood is often used as a surrogate tissue to 
examine systemic alterations in DNA methylation in response to exposure or disease. When 
analyzing blood in EWAS studies, it is of importance to consider that epigenetic alterations 
detected in blood may not necessarily reflect changes occurring in other tissues. Another issue 
when analyzing blood is the heterogeneity of blood. Blood is composed of a broad mixture of 
multiple cell types, and therefore the proportion of cell types in a blood sample should be taken 
into account as each cell type holds its own specific DNA methylation pattern (172). Thus, inter-
individual variation in blood cell proportion can potentially confound the observed relationship 
between methylation patterns and the exposure of interest. A technique to quantify blood cell 
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proportions is fluorescent activated cell sorting (a.k.a. FACS) which is an expensive method 
that requires fresh blood samples. Another approach to account for the problem with blood 
heterogeneity is to use a reference epigenome to identify differently methylated regions (173). 
While the reference epigenome is a project under development, the analogue human genome 
map is well-established (173). Inter-individual variation in DNA methylation appears to be 
common among individuals, and may be heavily influenced by underlying genetic differences 
(174). Until there is a reference epigenome available, it is a challenge to give biological meaning 
to observed differences in methylation patterns, e.g., between siblings born before and after 
maternal bariatric surgery. 
The genotype is typically the same for an individual throughout the life span. However, the 
epigenetic profile of an individual may change over time (149). Changes to the epigenome may 
occur during aging and in response to exogenous exposures (e.g., nutrition and smoking). This 
increases the risk of misclassification or other types of bias, and thus caution is required when 
interpreting results from EWAS studies. Additional problems arise when interpreting results 
from cross-sectional EWAS studies, where the study design makes is impossible to establish 
whether epigenetic dysregulation leads to disease or vice-versa, thus highlighting the issue of 
reverse causality.     
 
Study one, strengths and limitations 
The major strength of Study one was in reducing observed and unobserved confounding due to 
maternal genetic, social and life style factors that were constant between pregnancies of the 
same woman. However, even in a sibling study, residual confounding can never be excluded, 
due to genetic differences between full siblings (who share approximately 50% of their 
segregating genes), or due to changes in environmental or life style circumstances between 
pregnancies. Unobserved environmental changes affecting GWG, intrauterine environment and 
offspring weight may have occurred in between pregnancies since the mean time interval 
between pregnancy and bariatric surgery was large. Although maternal genetics are fixed 
between pregnancies, the contributions of the maternal and paternal genomes to the child 
genome differ between siblings. It is strength that we had access to detailed measured data on 
GWG, which made it possible to assess the effects of GWG in different trimesters. 
Nevertheless, using data from national registers that were collected routinely may lead to some 
degree of non-differential misclassification.  
The main limitations to Study one were the small sample size that reduced statistical power, 
and changes in surgical procedures over a long period of time (between 1980 and 2006), from 
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the less effective to the more effective surgical procedures, which resulted in greater weight 
loss after surgery later in the study period. The small sample size made stratification on surgery 
procedure impossible, so we were unable to draw conclusions on effects from specific bariatric 
surgery procedures in studies one and two. Moreover, differences in maternal illness, 
medication and behaviors, e.g., smoking or use of alcohol, between pregnancies are not 
accounted by study design or taken into account by adjustments since we had no access to this 
information.   
 
Study two, strengths and limitations 
A major strength of Study two was in reducing observed and unobserved confounding, by 
study design, due to maternal genetic, social and lifestyle factors, at least to the extent that they 
are held constant between pregnancies of the same woman. In addition, we had access to 
detailed objectively measured data on both maternal GWG, pre-pregnancy BMI, BMI at 
surgery and follow-up, and offspring birth weight and BMI at four and six years (same data as 
for Study one). 
This study also has some limitations. Although the size of our population may appear small, it 
is of comparable size to previous research with a similar design involving 25 siblings born 
before and after maternal BPD (48, 145). We used DNA extracted from whole blood, as it is more 
convenient and acceptable than tissue biopsies, especially in children. As previously described 
blood is a heterogeneous tissue composed of a broad mixture of multiple cell types. Thus, 
blood may not necessarily reflect changes occurring in other tissues. However, the overall 
impact of tissue-specific DNA methylation is minor given the known similarities in 
methylation patterns across tissues (175). We did not stratify for sex in our gene methylation 
analyses as previous research has failed to detect sex-specific methylation patterns (176). Due to 
the before-after design of our study, the age differences between the two sibling groups were 
large. Although DNA methylation is relative stabile over time (175), age-related differential 
methylation has been reported among twins (177-179). However, age-related differential 
methylation has been shown to represent a small proportion of CpG sites (1.3%; 360 sites on 27 
578 CpGs analyzed) (180) and to be site- and location-specific (181). Given the lack of sex-
specific methylation patterns and the limited impact of age on gene methylation, it is reasonable 
to assume little impact of sex and age in the present study.    
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7.1.2 Data collection two 
RYGB surgery is a well-established surgical procedure in Sweden, and is conducted in the 
same way in the five participating surgical centers (107). Nevertheless, the hospitals have 
somewhat different pre- and post-surgery counseling regarding diet and PA, which may have 
had some impact on participants’ PA before and after surgery. Furthermore, discrepancies in 
hospital routines for identifying possible study participants made it impossible to collect 
information on patients who declined to participate in the study. Thus, we may have ended up 
with a study sample of people who were more positive to participating in research, and may 
have somewhat different baseline characteristics compared with individuals who declined 
participation.  
 
Studies three and four, strengths and limitations 
The major strength of these studies are the longitudinal design with standardized three months 
pre- and nine months post-surgery objectively measured PA, SB and anthropometrics, enabling 
control, by design, of all measured effects that are constant from pre- to post-surgery. 
Anthropometrics on weight, height, waist circumference, and body composition were collected 
with standardized best practice methods and measured by the current PhD students before and 
after surgery. Furthermore, PA and SB were measured with a high quality tri-axial 
accelerometer, accurately estimating PA (159), and the time frame between home visits gave 
limited room for seasonal differences in PA and SB (182). However, recent Swedish data 
indicate that the seasonal differences in PA and SB are marginal (183). In addition, both the 
monitor wear time protocol and data processing protocol followed best practices (184). The 
accuracy of the accelerometer in measuring different types of physical activities, e.g., weight 
lifting and bicycling is unknown. However, research has shown that activity types are 
performed with similar frequencies before and after bariatric surgery (128).  
BIA is useful in describing mean body composition for groups of individuals, but bias at 
individual level may limit its usefulness, especially among the obese (185). Further problems 
with BIA analyses are its dependence on hydration status (186), and that there are a lot of 
different equations used to interpret the results from BIA outputs (187, 188). For severely obese 
individuals undergoing bariatric surger, the BIA method and suggested equations for analyzing 
body composition show large fluctuations and limited comparability when compared with more 
accurate dual-energy X-ray absorptiometry measurements (189).    
 
Accelerometers 
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Accelerometers, such as the Actigraph GT3X+, have been shown to accurately estimate PA 
(159), while estimates of really high intensity work is a well-known limitation of accelerometers, 
described as the “ceiling” effect (190).  Data for cut-offs developed using tri-axial data (Vm) from 
the GT3X+ accelerometer or other tri-axial accelerometers are sparse (163). Thus, it is 
challenging to compare our data on time spent in different PA intensities with other studies 
using older uni-axial accelerometers, such as the Actigraph GT1M accelerometer (164). 
Furthermore, the cut-offs developed for GT3X+ (Vm) to assess PA in different intensities differ 
considerably between studies. For example, MVPA was defined as >2690 cpm in one 
validation study of 28 men and 22 women (mean age = 26.9 SD 7.7 years) (191), whereas 
another validation study of 16 men and 15 women (mean age = 47.1 SD 3.5 years) defined 
MVPA as >3208 cpm (163). In children, a recent validation study of 19 boys and 12 girls (mean 
age = 14.7 and SD 1.0 years) defined MVPA as > 2114 cpm (163), whereas a validation study of 
27 boys and 22 girls (mean age = 10.8 and SD 1.9 years) by Hanggi et al. defined MVPA as > 
3360 cpm (164). This discrepancy clearly demonstrates the problem of using cut-offs to define 
different levels of PA. Furthermore, it highlights the importance of developing standardized 
specific cut-offs for each accelerometer model and age range owing to the importance of PA 
for health and the wide use of PA as exposure or outcome in epidemiological research (192).    
Most published studies on the assessment of PA with accelerometers use uni-axial data from 
the vertical axis (Vt). For example, the Actigraph GT1M has been used for data collection in 
the well-known NHANES study (193). However, data can be comparable between the GT1M 
and GT3X+ when both accelerometers are set to collect data in the vertical axis plane (191). In 
theory, analyzing all three axes from the GT3X+ should provide a more accurate assessment of 
PA. Nevertheless, data show that the additional information obtained from analyzing three axes 
is not more efficient or accurate than one axis when compared with oxygen consumption (194). 
On the other hand, there are studies indicating that tri-axial accelerometers are more accurate 
than uni-axial accelerometers when assessing PA and energy expenditure in children and adults 
(195, 196). There may be several reasons why the GT3X+ does not seem to assess PA more 
accurately than the GT1M. First, there is evidence to support the notion that the vertical axis is 
the most important axis when assessing PA (195). Second, most validation studies are performed 
on a treadmill, with no or very little incline, and therefore very little opportunity for antero-
posterior and medio-lateral axis movements. Thus, the treadmill may not elicit enough force to 
detect motion in the antero-posterior or medio-lateral axis (194). Perhaps accuracy of assessing 
PA is more accurate with the GT3X+ than with the GT1M under free-living conditions, which 
involve all three-dimensional movement patterns.  
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The most recent definition of SB is “waking behaviour characterized by an energy expenditure 
less than 1.5 MET:s while in sitting or reclining posture” (197). In the analyses in studies three 
and four, intensity lower than 1.5 MET:s but no information on posture was applied to  define 
SB. Thus, it cannot be excluded that some of the time spent sedentary has been misreported as 
standing time, which is not covered by the definition of SB. However, this potential 
misreporting is most likely equivalent in the before and after RYGB surgery measurements. 
The GT3X+ accelerometer has an inclinometer that can be used to detect posture. However, 
research has shown limited validation of the inclinometer (164). For example, in a sample of 49 
children, Hanggi et al. (164) showed that the standing position was misclassified 75% of the time 
as sitting and correctly identified only 20% of the time as the standing position. Hence, posture 
classification by the inclinometer should be interpreted cautiously. For more valid assessment 
of postures, the activPal™ has been recommended (198).   
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8 IMPLICATIONS OF RESULTS  
8.1 STUDY ONE 
This study shows that there are positive associations, in women undergoing bariatric surgery, 
between differences in total GWG and GWG in the second trimester and differences in 
offspring birth weight. In accordance with previous research (199), we did find a significant 
decrease in birth weight in AMS siblings compared with BMS siblings. On the other hand, no 
associations were found between differences in GWG and differences in children’s BMI in 
preschool age, which may be due to low statistical power (39 sibling-pairs). One possible 
explanation for the positive associations between differences in GWG from one pregnancy to a 
later pregnancy of the same women with differences in offspring birth weight might be that 
higher GWG in total or in the second trimester before rather than after surgery may be related 
to higher delivery of glucose and fatty acids to the developing fetus, and thus higher birth 
weight before than after surgery (200).  Given the obesity epidemic and the fact that a one 
kilogram increment in birth weight increases the risk of overweight in adolescence by 30% to 
50% (201), evidence that both total GWG and second trimester GWG are associated with 
increased differences in birth weight may be of importance when considering interventions to 
reduce the intergenerational vicious cycle of high maternal GWG and childhood obesity in the 
next generation (Figure 9).  
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Figure 9. Schematic figure over the vicious circle of high maternal GWG and childhood obesity 
in the next generation 
 
 
Similar to findings presented by Aricha-Tamir et al. (199), we detected a significant decrease in 
gestational-age adjusted birth weight in offspring born after maternal surgery compared with 
siblings born before such surgery. The timing of GWG and birth weight is not fully understood. 
We found an association between GWG in the second trimester and birth weight, which is in 
line with previous findings indicating that GWG in the second trimester is most strongly 
associated with birth weight (202). Although intervention research on how to modify GWG 
during pregnancy is sparse, there are data indicating that excessive GWG may be preventable 
(203). Thus, our results indicating an association between greater second trimester GWG and 
increased birth weight may be important to consider for future interventions to diminish 
excessive GWG.  
8.2 STUDY TWO 
The main findings were that maternal bariatric surgery, with subsequent weight loss between 
pregnancies, is associated with overrepresentation of DMS in genes involved in cytokine 
inflammatory signaling and T2D signaling when comparing BMS and AMS siblings.  
Despite the observed differences between BMS and AMS siblings in the methylome, 
interpretation of these data should be made cautiously. Intragenic methylation may affect gene 
expression differently, where methylation in the gene body 5’UTR (5' untranslated region) and 
3’UTR correlates with increased gene expression, whereas methylation in the promoter region 
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is associated with decreased gene expression (156). The influences on risk of development of 
obesity in offspring through an altered methylome remain uncertain. Nevertheless, this study 
demonstrated epigenetic effects on sibling methylome of the genes involved in T1D, T2D and 
obesity from maternal bariatric surgery, with subsequent weight loss between pregnancies. In 
accordance with our findings, when comparing BMS and AMS siblings whose mothers 
underwent BPD, Guenard and colleagues found an overrepresentation of pathways involved in 
inflammation (145), T1D, T2D and IGF1 signaling (48), and an overrepresentation of differently 
methylated genes such as HLA-DQB1 associated with T1D and FTO and ATPase, class V, type 
10A (ATP10A) associated with T2D (48) Hence, alterations in the methylome of offspring born 
after maternal bariatric surgery may encompass surgical procedures other than BPD.  
A maternal high-fat diet in rats has been shown to be associated with increased birth weight, 
increased leptin levels and hypermethylation of the POMC promoter in offspring (204). 
Likewise, we observed hypermethylation of the POMC promoter in BMS siblings, who were 
exposed to an obesogenic intrauterine environment during fetal life, compared with AMS 
siblings, exposed to a less obesogenic intrauterine environment. Our findings are in line with 
previous data implying increased long-term risk from an obesogenic intrauterine environment, 
in terms of dysregulation of food intake, energy balance and obesity in offspring, even 
independent of genetic background (205, 206). Thus, maternal bariatric surgery, with subsequent 
interpregnancy weight loss, may constitute a less obesogenic intrauterine environment with less 
circulating glucose and free fatty acids, which may alter the methylome of obesity and T2D-
related genes, and thereby reduce the long-term risk of developing obesity and T2D in 
offspring.  
8.3 STUDY THREE 
This study shows that that there were no significant differences in MVPA, MVPA in 10-minute 
bouts, LPA or time spent sedentary from three months before to nine months after surgery in 
women undergoing RYGB, despite substantial weight loss. However, women with higher pre-
surgery PA decreased their PA post-surgery while women with lower PA increased their PA, 
which may reflect a regression towards the mean. RYGB surgery enforces caloric restriction 
with post-surgery reductions in daily-consumed calories and FFM (207). Data on 48 overweight 
subjects in a randomized trial, using doubly labeled water, indicate that a caloric deficit is 
associated with a decrease in PA (208). Furthermore, whether a person is prone to engage in 
habitual PA is partly determined by genetic variation (209). Collectively, these circumstances 
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may at least partly explain why women undergoing RYGB fail to increase PA post-surgery 
despite substantial weight loss.  
The women in our study are, compared with a Swedish sample of 1172 participants (54% 
women, mean age 45, 10% obese) measured longitudinally by the GT1M accelerometer 
between 2001 and 2008 (210), more physically active and spend less time sedentary. In the study 
by Hagströmer et al. 633 women spent 24 (SD 21) minutes per day in MVPA and 532 (SD 71) 
minutes per day in SB, whereas women undergoing RYGB in our study spent 30.9 (SD 17.7) 
and 32.1 (SD 23.5) minutes per day in MVPA, and 430.2 (SD 141.5) and 420.7 (SD 128.8) 
minutes per day in SB three months before and nine months after surgery, respectively.  
In accordance with our results, previous research has failed to detect a significant change in PA 
from pre- to post-surgery among patients undergoing RYGB when PA is measured objectively 
(127). Our findings of pre-surgery PA as an independent factor for post-surgery PA, in addition 
to data indicating that patients undergoing RYGB fail to increase PA from pre- to post-surgery, 
despite great weight loss, highlight the importance of pre- and post-surgery interventions 
aiming to increase PA. Furthermore, awareness should be raised as a large proportion of 
women undergoing RYGB (depending on the PA parameter, 46.4% to 58.9% of the 
participants decreased their PA and 51.8% increased SB) decrease PA and increase time spent 
sedentary from before to after surgery despite substantial weight loss.  
8.4 STUDY FOUR 
This study shows that that there are no significant differences in PA or SB between three 
months before and nine months after surgery in spouses or women who undergo RYGB. 
However, in children, MVPA and LPA decrease significantly, and SB increases significantly, 
between pre- and post-maternal RYGB surgery. Forty-four percent of spouses and 39% of 
children decrease time spent on MVPA, and increase time spent sedentary, between pre- and 
post-surgery. One possible explanation for the observed decrease in PA and the observed 
increase in SB among children between pre- and post-maternal surgery is the observed decline 
in PA with age, especially during adolescence (211). In conflict with our findings, the currently 
only published study with a similar design and study population reported an increase in PA 
among adult family members and children from pre- to post-RYGB surgery (212). However, the 
researchers used a seven-day PA-recall questionnaire, which is susceptible to misreporting of 
PA (132), especially among patients undergoing RYGB surgery (127). Consequently, it is 
questionable whether the results presented by Woodard et al. (212) would have been the same if 
PA had been measured objectively. From a policy perspective, given that the PA of the family 
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members of the women who had undergone RYGB either remained unchanged or decreased 
post-surgery, there should be an emphasis on interventions designed to increase PA within the 
family between pre- and post-surgery. Additionally, awareness should be raised that children 
significantly decrease time spent physically active, and that they increase time spent sedentary 
between maternal pre- and post-RYGB surgery.   
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9 FUTURE RESEARCH PERSPECTIVES 
 
The large number of bariatric surgical procedures conducted annually in Sweden and many 
other developed countries(106), in combination with the limited scientific evidence of long-term 
effects of such surgery in patients and family members, should motivate researchers to expand 
this research field in the future. The existing obesity epidemic will most likely maintain the 
demand for surgical interventions, given that there is no comparable alternative treatment for 
obesity in the future.  
Bariatric surgery has been associated to decrease in adverse obstetric and perinatal effects in 
women with severe obesity (213). However, the effects on child and adolescent obesity in 
comparison s between BMS and AMS siblings are less clear. While Kral et al. (47) have 
presented results indicating lower rates of obesity in AMS siblings compared with BMS 
siblings, we were unable to detect such a difference in our sample. It would be of interest to 
replicate our study in a larger sample to include more data on the BMI of sibling-pairs of six 
and four years of age stratified according to the surgical procedures most often used in Sweden 
today, i.e., laparoscopic gastric bypass and, to an increasing extent, also gastric sleeve 
operations (106). Such a study would make future results more comparable with the results of 
Kral et al. who studied the effects of maternal BPD on offspring BMI (47). In accordance with 
Aricha-Tamir et al. (199), we reported a decrease in birth weight in AMS siblings compared with 
BMS siblings. A recent publication by Amsalem et al. (124) reported a significant decrease in 
pregnancy complications at the second subsequent pregnancy following bariatric surgery. 
Furthermore, the authors reported that women had essentially unchanged pre-pregnancy BMI 
for both gestations following surgery. Thus, it would be of interest further to investigate the 
effects of interpregnancy weight gain, total and trimester-specific GWG, offspring birth weight 
and BMI at four and six years in multiple pregnancies following bariatric surgery, using our 
study sample. 
Interest in understanding the associations between epigenetic changes and disease outcomes, 
together with the fast developing EWAS technique, has rapidly increased during the last 
decade.  Knowledge in this area has changed considerably since we started the project. Recent 
data has indicated that inter-subject variation in leukocyte distribution may confound the 
observed relationship between methylation and the observed outcome (different methylation of 
obesity-related genes). Moreover, the use of a surrogate tissue (in our case the use of blood) to 
examine systemic alterations in DNA methylation may not necessarily reflect changes 
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occurring in other tissues (149). In addition, there is recent data indicating epigenetic intra-
individual differences after RYGB in muscle tissue (139). Thus, it would be of interest to conduct 
a similar data collection to ours for studies one and two, but this time to collect whole blood 
sorted with FACS as well as biopsies from muscle and fat tissue in BMS and AMS siblings. 
Moreover, it would be of great interest to see whether the observed methylation differences 
between BMS and AMS siblings are correlated with actual mRNA expressions (145), and with 
other epigenetic gene regulating mechanisms such as histone modifications (214). Another 
possible approach would be to collect FACS-sorted whole blood and muscle and fat-tissue 
biopsies from children. Today, several of the mothers included in data collection two have 
given birth after RYGB surgery, which enables comparisons of epigenetic patterns in obesity-
related genes between siblings born before and after maternal RYGB.   
In studies three and four, several RYGB patients had difficulties complying with prescribed PA 
recommendations after surgery, and – even more alarmingly – several women and family 
members (especially children) decreased PA and increased SB from pre- to post maternal 
RYGB surgery. Thus, strategies for assisting RYGB patients and family members to increase 
and maintain higher PA levels from before to after maternal RYGB are of importance. It would 
be of great interest to study the effects of pre- and post-surgery PA counseling on PA and SB in 
patients undergoing RYGB and family members. Similar study design and measurements as 
used in studies three and four could be applied in the PA and SB assessments. However, I 
would personally like to focus the analyses more on time spent sedentary, and use an 
inclinometer such as the activPal™ to detect body posture, since SB has recently been 
recognized as a risk factor for numerous disease states independent of PA (215). The use of both 
the GT3X+ and activPal™ to estimate SB would enable us to assess SB with decent validity 
(164, 198) according to the latest definition of SB (197). Barriers to engage in PA may be more 
common among obese adults, and bariatric surgery patients in particular frequently feel too 
overweight to exercise, experiencing musculoskeletal problems, having past negative 
experiences, or having fear of exercise-related injuries (216).  Hence, it may be more appropriate 
to aim at reducing time spent sedentary among patients undergoing RYGB, since reduced SB 
has beneficial effects on health independent of PA. Furthermore, reduced SB may be easier to 
achieve in RYGB candidates compared with increased PA, which is associated with both 
physical, and psychological barriers in RYGB patients (216).  
There is preliminary data from the “Bariactive Study” indicating an increase in steps per day 
from before to after surgery in patients undergoing bariatric surgery. So far, the preliminary 
results are based on ”standard care” data from the Longitudinal Assessment of Bariatric 
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Surgery-2 study (128) and PA counseling data from the “Bariactive Study” (217). If the final 
results of the “Bariactive Study” show an increase in steps per day from before to after surgery 
in patients undergoing bariatric surgery, it would be of interest to test a similar intervention 
design, with a focus on objectively accelerometer-measured PA and SB, in a Swedish sample 
of patients undergoing RYGB.  
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10 CONCLUDING REMARKS 
 
• Women undergoing bariatric surgery show a positive association between differences in 
total and second trimester maternal GWG and differences in offspring birth weight, but 
no association with offspring BMI at pre-school age.  
 
• Maternal bariatric surgery, with subsequent weight loss between pregnancies, is 
associated with overrepresentation of differently methylated sites in genes involved in 
inflammatory signaling and T2D signaling, and differences in the methylation of genes, 
such as HLA-DQB1, POMC, IGF2, INSR, FTO and TNF, associated with T1D, T2D 
and obesity, when comparing siblings born before and after maternal bariatric surgery.   
 
• There are no significant differences in objectively measured PA or time spent sedentary 
from three months before to nine months after surgery in women undergoing RYGB 
despite substantial weight loss. 
 
• There are no significant differences in objectively measured PA or SB between three 
months before and nine months after surgery in spouses or women who undergo 
RYGB. However, in children, PA decreases significantly, and time spent sedentary 
increases significantly from before to after maternal RYGB surgery. 
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11 POLPULÄRVETENSKAPLIG SAMMANFATTNING 
Sjukdomar kopplade till övervikt och fetma som hjärtinfarkt, diabetes samt olika cancerformer 
leder enligt WHO årligen till mer än 2.8 miljoner dödsfall världen over. I Sverige beräknas 
ungefär 50% av männen, 40% av kvinnorna och 10% av barnen vara överviktiga vilket speglar 
en ökning med mer än 50% från 1980 till 2012. Därutöver har prevalensen av övervikt hos 
gravida kvinnor i Sverige ökat markant från 10.6% år 1982 till 24.8% år 2010. Detta är 
alarmerande eftersom övervikt och kraftig viktuppgång under graviditet är starkt kopplat till 
förlossningskomplikationer samt ökad risk för fetma och metabola sjukdomar hos avkomman.  
 
Kirurgisk behandling av fetma är idag den mest effektiva behandlingen mot fetma, vilken i 
majoriteten av fallen resulterar i bestående viktminskning samt positiva effekter på flertalet 
sjukdomar kopplade till fetma. Nittiotvå procent av all kirurgisk behandling år 2013 i Sverige 
var s.k. gastric bypass-kirurgi vilken har en kombinerad effekt av minskat födointag genom 
förminskning av magsäcken samt ett minskat upptag av näringsämnen genom omkoppling av 
tunntarmen. Effekter av kirurgisk behandling mot fetma på förändring av fysisk aktivitet och 
stillasittande beteende hos patienter vilka genomgår kirurgi och familjemedlemmar, samt 
effekter på reglering av gener som är kopplade till fetma i avkomma född efter jämfört med 
avkomma född före kirurgisk behandling av fetma är till stor del okända.  
 
Avhandlingens syfte var att, via upprepade mätningar inom samma individ, studera effekter av 
kirurgisk behandling mot fetma hos kvinnor på viktuppgång under graviditet och fostrets 
födelsevikt samt skillnader i avkommans reglering av gener som är kopplade till fetma 
beroende av om avkomman är född före eller efter mammans kirurgi. Därutöver studerades 
förändring i fysisk aktivitet och stillasittande beteende hos kvinnor som genomgår gastric 
bypass-kirurgi och hennes familj från tre månader före till nio månader efter kirurgi.  
 
Studie ett visade att det finns positiva associationer, hos kvinnor som genomgår kirurgisk 
behandling mot fetma, mellan skillnader i viktuppgång mellan graviditeter och skillnader i 
barnets födelsevikt. 
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Studie två visade att kirurgisk behandling mot fetma hos kvinnor, med medföljande 
viktnedgång mellan graviditeter, är kopplat till förändring av genaktivitet med kopplingar till 
inflammation och diabetes vid jämförelse av syskon födda före respektive efter mammans 
kirurgiska behandling.   
 
Studie tre visade att det inte finns några skillnader i objektivt mätt fysisk aktivitet eller 
stillasittande beteende från tre månader innan till nio månader efter kirurgi hos kvinnor som 
genomgår gastric bypass-kirurgi. 
 
Studie fyra visade att objektivt mätt fysisk aktivitet samt stillasittande beteende inte förändras 
från tre månader innan till nio månader efter kirurgi hos partners medan barn minskar fysisk 
aktivitet och ökar stillasittande beteende när mamman genomgår gastric bypass-kirurgi.  
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